Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
4.120
+0.040 (0.98%)
Jul 28, 2026, 10:45 AM EDT - Market open
Aligos Therapeutics Stock Forecast
ALGS's stock price has decreased by -55.64% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 analysts polled by S&P Global, Aligos Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $56.29. The average 1-year stock price forecast is 1,266.26% higher than the current stock price, while the lowest is $20 (+385.44%) and the highest is $175 (+4,147.57%).
Price Target: $56.29 (+1,266.26%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aligos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +1,113.59% | Jul 14, 2026 |
| Lake Street | Lake Street | Buy Maintains $45 | Buy | Maintains | $45 | +992.23% | Jun 1, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $20 | Buy | Maintains | $20 | +385.44% | May 29, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $175 | Buy | Maintains | $175 | +4,147.57% | May 8, 2026 |
| Jefferies | Jefferies | Buy Initiates $48 | Buy | Initiates | $48 | +1,065.05% | Mar 19, 2026 |
Financial Forecast
Revenue This Year
21.68M
from 2.19M
Increased by 891.61%
Revenue Next Year
5.00M
from 21.68M
Decreased by -76.93%
EPS This Year
-7.11
from -2.45
EPS Next Year
-3.99
from -7.11
EPS and Forward PE are based on non-GAAP adjusted numbers.